Accessibility Menu

MedMira(FRA) 47M

Market Cap€25.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€0.04
+21.31%
+0.01Today

MedMira Financials at a Glance

Market Cap

€25.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€0.23

Net Income (TTM)

-€1.87

EPS (TTM)

-€0.00

P/E Ratio

-13.70

Dividend

€0.00

Beta (Volatility)

-0.27 (Low)

Price

€0.04

Volume

0

Open

€0.04

Previous Close

€0.04

Daily Range

€0.04 - €0.04

52-Week Range

€0.02 - €0.05

Estimated Earnings Date

N/A

47M News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MedMira

MedMira, Inc. is a biotechnology company, which through its subsidiaries, engages in the research, development, manufacture, and commercialization of diagnostics and technology platforms. Its tests provide hospitals, labs, clinics, and individuals with rapid diagnosis for diseases, including human immunodeficiency virus and hepatitis C. It offers its tests under the Reveala, Multiplo, and Miriad brands. The company was founded by Hermes Hermes Chan and Carlina Hui in 1993 and is headquartered in Halifax, Canada.

Industry

Healthcare Equipment and Supplies

CEO

Hermes Hermes Chan

47M Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-7.30%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€25.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

701.73M

Volume

0

Avg. Volume

4.546

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

MedMira Performance Analysis

MedMira annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-07-31EUR 674,401N/A
20232023-07-31EUR 306,261-54.6%
20242024-07-31EUR 281,155-8.2%
20252025-07-31EUR 157,612-43.9%
MedMira annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-07-31EUR -0.00N/A
20232023-07-31EUR -0.0042.1%
20242024-07-31EUR -0.0022.2%
20252025-07-31EUR -0.0030.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€0.15

+3.9%

Gross Profit

-€0.04

+0.3%

Gross Margin

-26.64%

+0.1%

Market Cap

€25.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-€0.30

+0.5%

EBITDA

-€0.12

+0.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€10.91

+5.7%

Total Debt

€10.91

+1.1%

Accounts Receivable

€0.81

+1.0%

Inventory

€0.12

+0.8%

Long Term Debt

€1.58

+0.7%

Short Term Debt

€9.33

+1.2%

Return on Assets

-82.42%

+0.9%

Return on Invested Capital

18.48%

+1.1%

Free Cash Flow

-€0.10

+0.2%

Operating Cash Flow

-€0.10

+0.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About 47M

What is the current price of MedMira?

MedMira is trading at €0.04 per share.

What is the 52-week range for MedMira?

Over the past 52 weeks, MedMira has traded between €0.02 and €0.05.

How much debt does MedMira have?

As of the most recent reporting period, MedMira reported total debt of €10.91M.

How much cash does MedMira have on hand?

MedMira reported €0.00 in cash and cash equivalents in its most recent financial results.

What is MedMira’s dividend yield?

MedMira does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.